[The use of galantamine bromhydrate (nivaline) in the paralytic sequelae of poliomyelitis, neuraxitis and in muscular dystrophy].
D002800:Cholinesterase Inhibitors; D004679:Encephalomyelitis / Q000628:therapy*; D005702:Galantamine; D006801:Humans; D009136:Muscular Dystrophies / Q000628:therapy*; D010276:Parasympatholytics / Q000628:therapy*; D011051:Poliomyelitis / Q000628:therapy*
D002800:Cholinesterase Inhibitors; D010276:Parasympatholytics; D005702:Galantamine
CHOLINESTERASE/antagonists; ENCEPHALOMYELITIS/therapy; MUSCULAR DYSTROPHY/therapy; PARASYMPATHOLYTICS/therapy; POLIOMYELITIS/therapy